» Articles » PMID: 10728353

Serial Echocardiographic Assessment of Left Ventricular Dimensions and Function After Myocardial Infarction in Mice

Overview
Journal Cardiovasc Res
Date 2000 Mar 23
PMID 10728353
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To test the usage of serial echocardiography in mice with induced myocardial infarct (MI) and to characterize the mouse model of MI.

Methods: C57 mice underwent open-chest surgery to induce left coronary artery occlusion or sham-operation (SH). Echocardiography was performed before and at 1, 2.5, 6 and 9 weeks after surgery. Left ventricular end diastolic and end systolic dimensions (LVEDd, LVESd) and fractional shortening (FS) were measured. Haemodynamics was determined at week 9 by LV catheterization and hearts were examined morphologically.

Results: Post-infarct mortality was 46% (10/22), of which, 70% died of acute heart failure or LV rupture within the first week. LV dimensions and FS remained stable in SH group (n = 10) during the study period. In surviving MI mice (n = 12), there was modest LV dilatation and fall in FS at week 1. Compared with week 0 values, there were progressive increase in LVEDd (+50(-)+66%) and LVESd (+124(-)+171%), and decline in FS (-53(-)-73%) during the 2.5-9 week period. Infarcted mice also had lower LV systolic pressure (LVSP), dP/dtmax and dP/dtmin (all P < 0.01 vs. SH group). Infarct size, LVSP and dP/dt significantly correlated with FS and LV dimensions (r = 0.61-0.80, all P < 0.01).

Conclusions: LV remodeling and dysfunction in mice with MI are time-dependent processes and early remodeling seems associated with high risk of rupture and acute pump failure. Our findings provide a baseline description of this murine model and confirm echocardiography as a reliable means to serially assess changes of cardiac structure and function after MI.

Citing Articles

Heart Failure Post-Myocardial Infarction Promotes Mammary Tumor Growth Through the NGF-TRKA Pathway.

Tani T, Oikawa M, Misaka T, Ishida T, Takeishi Y JACC CardioOncol. 2024; 6(1):55-66.

PMID: 38510296 PMC: 10950436. DOI: 10.1016/j.jaccao.2023.10.002.


The Flt3-inhibitor quizartinib augments apoptosis and promotes maladaptive remodeling after myocardial infarction in mice.

Monogiou Belik D, Bernasconi R, Xu L, Della Verde G, Lorenz V, Gruterich V Apoptosis. 2023; 29(3-4):357-371.

PMID: 37945814 PMC: 10873224. DOI: 10.1007/s10495-023-01911-8.


The role of Vav3 expression for inflammation and cell death during experimental myocardial infarction.

Zhang Y, Zhang Y, Song Q, Wang Y, Pan J Clinics (Sao Paulo). 2023; 78:100273.

PMID: 37591108 PMC: 10450409. DOI: 10.1016/j.clinsp.2023.100273.


Single-Dose Treatment with Rapamycin Preserves Post-Ischemic Cardiac Function through Attenuation of Fibrosis and Inflammation in Diabetic Rabbit.

Samidurai A, Saravanan M, Ockaili R, Kraskauskas D, Lau S, Kodali V Int J Mol Sci. 2023; 24(10).

PMID: 37240345 PMC: 10218967. DOI: 10.3390/ijms24108998.


Pericardial Grafting of Cardiac Progenitor Cells in Self-Assembling Peptide Scaffold Improves Cardiac Function After Myocardial Infarction.

Kanda M, Nagai T, Kondo N, Matsuura K, Akazawa H, Komuro I Cell Transplant. 2023; 32:9636897231174078.

PMID: 37191272 PMC: 10192947. DOI: 10.1177/09636897231174078.